For: | Suzuki H, Kikuta T, Inoue T, Hamada U. Time to re-evaluate effects of renin-angiotensin system inhibitors on renal and cardiovascular outcomes in diabetic nephropathy. World J Nephrol 2015; 4(1): 118-126 [PMID: 25664254 DOI: 10.5527/wjn.v4.i1.118] |
---|---|
URL: | https://www.wjgnet.com/2220-6124/full/v4/i1/118.htm |
Number | Citing Articles |
1 |
Yun Jung Oh, Sun Moon Kim, Byung Chul Shin, Hyun Lee Kim, Jong Hoon Chung, Ae Jin Kim, Han Ro, Jae Hyun Chang, Hyun Hee Lee, Wookyung Chung, Chungsik Lee, Ji Yong Jung, Tatsuo Shimosawa. The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease. PLOS ONE 2017; 12(1): e0170874 doi: 10.1371/journal.pone.0170874
|
2 |
Wen-Yeh Hsieh, Teng-Hsiang Chang, Hui-Fang Chang, Wan-Hsuan Chuang, Li-Che Lu, Chung-Wei Yang, Chih-Sheng Lin, Chia-Chu Chang, Michael Bader. Renal chymase-dependent pathway for angiotensin II formation mediated acute kidney injury in a mouse model of aristolochic acid I-induced acute nephropathy. PLOS ONE 2019; 14(1): e0210656 doi: 10.1371/journal.pone.0210656
|
3 |
Dragana Lovre, Sulay Shah, Aanu Sihota, Vivian A. Fonseca. Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients. Endocrinology and Metabolism Clinics of North America 2018; 47(1): 237 doi: 10.1016/j.ecl.2017.10.006
|
4 |
Martin Chaumont, Aline Pourcelet, Marc van Nuffelen, Judith Racapé, Marc Leeman, Jean‐Michel Hougardy. Acute Kidney Injury in Elderly Patients With Chronic Kidney Disease: Do Angiotensin‐Converting Enzyme Inhibitors Carry a Risk?. The Journal of Clinical Hypertension 2016; 18(6): 514 doi: 10.1111/jch.12795
|
5 |
Ana María García-Prieto, Úrsula Verdalles, Marian Goicoechea. Use of renin–angiotensin–aldosterone system blockade in controversial chronic kidney disease populations. Medicina Clínica 2021; 156(11): 561 doi: 10.1016/j.medcli.2020.12.025
|
6 |
Alessandro Pini, Cristina Grange, Eleonora Veglia, Monica Argenziano, Roberta Cavalli, Daniele Guasti, Laura Calosi, Corrado Ghè, Roberto Solarino, Robin L. Thurmond, Giovanni Camussi, Paul L. Chazot, Arianna Carolina Rosa. Histamine H 4 receptor antagonism prevents the progression of diabetic nephropathy in male DBA2/J mice. Pharmacological Research 2018; 128: 18 doi: 10.1016/j.phrs.2018.01.002
|
7 |
F.C. Sasso, P.C. Pafundi, A. Gelso, V. Bono, C. Costagliola, R. Marfella, C. Sardu, L. Rinaldi, R. Galiero, C. Acierno, A. Caturano, C. de Sio, L. De Nicola, T. Salvatore, R. Nevola, L.E. Adinolfi, R. Minutolo, D. Giugliano, M.I. Maiorino, G. Riccardi, L. Bozzetto, V. Guardasole, R. Di Palo, O. Carbonara, M. Riccio, G. De Simone, L. Lucibelli, S. Masi. Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study. Nutrition, Metabolism and Cardiovascular Diseases 2019; 29(9): 923 doi: 10.1016/j.numecd.2019.05.065
|
8 |
Ana María García-Prieto, Úrsula Verdalles, Marian Goicoechea. Use of renin–angiotensin–aldosterone system blockade in controversial chronic kidney disease populations. Medicina Clínica (English Edition) 2021; 156(11): 561 doi: 10.1016/j.medcle.2020.12.023
|
9 |
Bibi S. van Thiel, Janette van der Linden, Yanto Ridwan, Ingrid M. Garrelds, Marcel Vermeij, Marian C. Clahsen-van Groningen, Fatimunnisa Qadri, Natalia Alenina, Michael Bader, Anton J. M. Roks, A. H. Jan Danser, Jeroen Essers, Ingrid van der Pluijm. In Vivo Renin Activity Imaging in the Kidney of Progeroid Ercc1 Mutant Mice. International Journal of Molecular Sciences 2021; 22(22): 12433 doi: 10.3390/ijms222212433
|
10 |
A.M. García-Prieto, Ú. Verdalles, A.P. de José, D. Arroyo, I. Aragoncillo, D. Barbieri, R.E. Camacho, M. Goicoechea. Renin–angiotensin–aldosterone system blockers effect in chronic kidney disease progression in hypertensive elderly patients without proteinuria: PROERCAN trial. Hipertensión y Riesgo Vascular 2024; 41(2): 95 doi: 10.1016/j.hipert.2023.11.005
|
11 |
Xiu Hong Yang, Yu Pan, Xiao Li Zhan, Bao Long Zhang, Li Li Guo, Hui Min Jin, Claudio Cabello-Verrugio. Epigallocatechin‐3‐gallate Attenuates Renal Damage by Suppressing Oxidative Stress in Diabetic db/db Mice. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/2968462
|
12 |
Na-Na Bao, De-Yang Kong, Dan Zhu, Li-Rong Hao. Influence of overexpression of SOCS2 on cells of DN rat. Asian Pacific Journal of Tropical Medicine 2015; 8(7): 583 doi: 10.1016/j.apjtm.2015.06.006
|